`
`Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution PITTSBURGH, May 16, 2011 /PRNewswire/
`
`Mylan Launches First Generic Version of Xibrom® Ophthalmic
`Solution
`
` ()
`
`
`
`
`
`
`
`
`
`
`
`PITTSBURGH, May 16, 2011 /PRNewswire/ Mylan Inc. (Nasdaq: MYL (http://studio
`5.financialcontent.com/prnews?Page=Quote&Ticker=MYL)) today announced that its subsidiary Mylan
`Pharmaceuticals Inc. has launched Bromfenac Ophthalmic Solution, 0.09% (Twice Daily Administration), based
`on a development and supply agreement with Coastal Pharmaceuticals. This product is the first generic
`version of ISTA's Xibrom® Ophthalmic Solution, 0.09% (Twice Daily Administration), a treatment for
`postoperative inflammation in patients who have undergone cataract extraction.
`
`Bromfenac Ophthalmic Solution had U.S. sales of approximately $116 million for the 12 months ending March
`31, 2011, according to IMS Health.
`
`Currently, Mylan has 169 ANDAs pending FDA approval representing $100.7 billion in annual sales, according
`to IMS Health. Fortyfive of these pending ANDAs are potential firsttofile opportunities, representing $25.8
`billion in annual brand sales, for the 12 months ending Dec. 31, 2010, according to IMS Health.
`
`Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides
`products to customers in more than 150 countries and territories. The company maintains one of the industry's
`broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the
`world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on
`respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com
`(http://www.mylan.com/). For more information about generic drugs, please visit www.ChoosingGenerics.com
`(http://www.choosinggenerics.com/).
`
`SOURCE Mylan Inc.
`
`RELATED LINKS
`http://www.mylan.com (http://www.mylan.com)
`
`http://www.prnewswire.com/newsreleases/mylanlaunchesfirstgenericversionofxibromophthalmicsolution121880548.html
`
`1/2
`
`Page 1 of 2
`
`SENJU EXHIBIT 2214
`LUPIN v. SENJU
`IPR2015-01099
`
`
`
`10/22/2015
`
`Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution PITTSBURGH, May 16, 2011 /PRNewswire/
`
`http://www.prnewswire.com/newsreleases/mylanlaunchesfirstgenericversionofxibromophthalmicsolution121880548.html
`
`2/2
`
`Page 2 of 2